Becton, Dickinson and Company

Financials

Panoramica Estratto Conto Statistiche Dividendi

Flusso di cassa derivante dalle attività operative 3.54 B4.65 B2.63 B2.99 B3.8 B3.43 B 3.39 B Flussi di cassa derivanti dalle attività di investimento -1.23 B-1.88 B-3.23 B-716 M-5.51 B-818 M -1.21 B Liquidità derivante dalle attività di finanziamento 22 M-3.31 B-591 M-1.96 B2.09 B-3.62 B -1.99 B Liquidità libera 2.73 B3.42 B1.66 B2.12 B3.07 B2.67 B 2.63 B

Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas. BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023.

BDX

Financials

Becton, Dickinson and Company

Notizie

BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension

BD Unveils HemoSphere Stream for Continuous Noninvasive BP Monitoring

BD riceve marchio CE per stent graft Liverty TIPS in Europa

ClearBridge Dividend Strategy Q1 2026 Portfolio Positioning

Le migliori opportunità azionarie di oggi con forti upside

Dividend Champion, Contender, And Challenger Highlights: Week Of March 29

Argus riduce il target di prezzo di Becton Dickinson per turbolenze di mercato

Best Dividend Aristocrats As Of March 20, 2026

Best Dividend Kings: March 2026

Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase?

Waters Corporation deposita i bilanci per l’acquisizione di SpinCo

I prezzi del settore Med Tech tornano piatti dopo un breve trend positivo, secondo Raymond James